MedTrace Logo

Pediatric Infectious Disease Precision Medicine Using Sequencing Evaluation of CSF

NCT03796546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2020-11-10

No results posted yet for this study

Summary

Prospective, multi-site, study to evaluate the diagnosis rate of DNA and RNA sequencing of cerebrospinal fluid for identification of pathogens directly in patients who have already had a spinal tap to evaluate for infection and were found to have a pleocytosis. Diagnostic rate and clinical utility of concurrent standard testing will be compared to diagnostic rate and clinical utility of DNA and RNA sequencing.

Conditions

Sponsors & Collaborators

  • Rady Children's Hospital, San Diego

    collaborator OTHER

  • IDbyDNA, Inc.

    lead INDUSTRY

Eligibility

Min Age
0 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-22
Primary Completion
2020-10-07
Completion
2020-10-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03796546 on ClinicalTrials.gov